Cécile Cauquil

Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre

Le Kremlin- Bicêtre

France

SCHOLARLY PAPERS

1

DOWNLOADS

113

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

The 2016-2019 ImmunoTOX Assessment Board Report: Results from a Descriptive Real-Life Study of a Collaborative Management of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors

Number of pages: 43 Posted: 03 Oct 2019
Gustave Roussy - Drug Development Department (DITEP), Universite Paris Descartes - Assistance Publique - Hôpitaux de Paris, Hôpital Marie-Lannelongue, University of Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Assistance Publique-Hôpitaux de Paris - Hepato-Biliary Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Assistance Publique-Hôpitaux de Paris, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, University of Paris-Saclay, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpital de Bicêtre, Peupliers Private Hospital, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Hôpitaux de Paris (AP-HP) - Hôpital Bicêtre, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, Hôpital Bicêtre, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, University of Paris-Saclay - Gustave Roussy Cancer Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Paris-Saclay - Gustave Roussy Cancer Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus and Hôpitaux Universitaires Paris-Sud-Hôpital Bicêtre
Downloads 113 (535,088)

Abstract:

Loading...

Patient care network; Multidisciplinary collaborative approach; Immune-related adverse event; Immune checkpoint inhibitor